Kalaris Therapeutics, Inc.

KLRS

—

Advanced chart & tools →

Kalaris Therapeutics, Inc.KLRS

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.85

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$165,000

Net income

$-43.44M

Net margin

-26326.1%

Gross margin

—

Dividends & financials

Kalaris Therapeutics, Inc. (KLRS) reported revenue of $165,000 and net income of $-43.44M, or $-2.85 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.